Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK

GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business

GSK is acquiring Nuvalent for $10.6 billion in cash, gaining three late-stage lung cancer therapies including two drugs already under FDA review.